Inhibition of MD2‐dependent inflammation attenuates the progression of non‐alcoholic fatty liver disease

Non‐alcoholic fatty liver disease (NAFLD) can progress to the more serious non‐alcoholic steatohepatitis (NASH), characterized by inflammatory injury and fibrosis. The pathogenic basis of NAFLD progressing to NASH is currently unknown, but growing evidence suggests MD2 (myeloid differentiation facto...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yali, Wu, Beibei, Zhang, Hailing, Ge, Xiangting, Ying, Shilong, Hu, Mengwei, Li, Weixin, Huang, Yi, Wang, Li, Chen, Chao, Shan, Xiaoou, Liang, Guang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783870/
https://www.ncbi.nlm.nih.gov/pubmed/29077272
http://dx.doi.org/10.1111/jcmm.13395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783870/
https://www.ncbi.nlm.nih.gov/pubmed/29077272
http://dx.doi.org/10.1111/jcmm.13395

Ejemplares similares